Skip to content

Estimating the incidence rate of enteric (typhoid) fever in India through a multi-center surveillance network of secondary care centers

Surveillance for Enteric Fever in India (SEFI), tier 2 - a hybrid surveillance approach to estimate the burden and incidence of enteric (typhoid) fever in India

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ISRCTN
Registry ID
ISRCTN72938224
Enrollment
150000
Registered
2020-05-06
Start date
2018-02-26
Completion date
Unknown
Last updated
2024-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Enteric fever Infections and Infestations Typhoid fever

Interventions

The site-specific incidence of enteric fever will be estimated through a hybrid approach - hospital-based surveillance combined with a healthcare utilization survey. Surveillance for enteric fever wil

Sponsors

Vellore Christian Medical College Foundation
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: For the hospital-based surveillance: 1. Age: greater than six months of age 2. Gender: Both 3. Patients presenting with fever who are hospitalized irrespective of the duration of fever or temperature 4. Patients with non-traumatic ileal perforation irrespective of history of fever or culture confirmation of typhoid For the healthcare utilization survey: 1. All those who normally reside and are present in the household during the entire period of survey – from the first day of survey to the last day of survey (both days inclusive). 2. All those who were known to be normally residing and had actually stayed in the household during a part of the survey (from the first day of survey to the last day of survey) but were not present at the time of visit of the interviewer. 3. All those who were known to be normally residing in the household and were not present at the time of visit of the enumerator but are expected to return by the last day of survey. 4. Age: all 5. Gender: both

Exclusion criteria

Exclusion criteria: For the hospital-based surveillance: 1. Patients who are not Indian citizens For the healthcare utilization survey: 1. Visitors to the household

Design outcomes

Primary

MeasureTime frame
Incidence of enteric fever in each of the study sites over the 24 months of surveillance measured by dividing the number of blood culture-confirmed enteric fever cases with the product of the hospital's catchment population and time period of surveillance. This crude incidence shall then be adjusted for the proportion of febrile patients from the catchment population seeking inpatient healthcare at other facilities, compliance to the study protocol, the sensitivity of blood culture and the probability of enteric fever patients being hospitalized.

Secondary

MeasureTime frame
1. Characterization of the clinical spectrum of enteric fever presenting at smaller (<350 beds) hospitals over the 24 months of surveillance- determined through estimating the prevalence of enteric fever among those hospitalized with a febrile illness, the prevalence of complications and severe disease among those presenting to surveillance facilities with enteric fever, and prevalence of antimicrobial resistance among S. Typhi/S. Paratyphi isolates 2. Estimates of the cost of treatment and productivity loss associated with a severe enteric fever over the 24 month period of surveillance- determined through calculating direct and indirect cost-of-illness for severe enteric fever and indebtedness directly attributable to the severe enteric fever illness episodes

Countries

India

Contacts

Public ContactJacob John
jacob@nssefi.org+91 9442631628

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 14, 2026